Franklin Street Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Franklin Street Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-80,000	Closed	-$1.36M	–	226
2014 Q4	$1.36M	Sell	80,000 -50,000	-38%	-$703K	0.26%	94
2014 Q3	$1.55M	Hold	130,000	–	–	0.29%	82
2014 Q2	$733K	Hold	130,000	–	–	0.14%	141
2014 Q1	$477K	Hold	130,000	–	–	0.1%	169
2013 Q4	$437K	Buy	130,000 +65,000	+100%	+$268K	0.09%	177
2013 Q3	$275K	Buy	+65,000	New	+$308K	0.06%	204

Franklin Street Advisors's AVNR Position: Q1 2015 in Review

Franklin Street Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 80,000 shares — an estimated $1.36M sold.

Franklin Street Advisors first reported a position in AVNR in Q3 2013 and held it in 6 quarters. The position peaked at $1.55M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Franklin Street Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Franklin Street Advisors sold 80,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $1.36M.
Franklin Street Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 6 quarters.
Franklin Street Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.55M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Franklin Street Advisors's 13F filing for Q1 2015, filed 8 Apr 2015.